Weekly Recap | bioAffinity Tech -47.94%, regains Nasdaq bid compliance then fadesWeekly Review·Sep 12 at 07:47 AMBIAF-15.88%
Weekly Recap | bioAffinity Tech +213.55%, CyPath Lung advances drive high-volume rallyWeekly Review·Sep 5 at 06:20 AMBIAF-15.88%
Weekly Recap | bioAffinity Tech -0.5%, spike fades after distribution dealWeekly Review·Aug 22 at 04:34 AMBIAF-15.88%
